226 related articles for article (PubMed ID: 15794385)
1. Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications.
Fox RJ; Fisher E; Tkach J; Lee JC; Cohen JA; Rudick RA
Mult Scler; 2005 Apr; 11(2):140-5. PubMed ID: 15794385
[TBL] [Abstract][Full Text] [Related]
2. Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities.
Traboulsee A; Dehmeshki J; Peters KR; Griffin CM; Brex PA; Silver N; Ciccarrelli O; Chard DT; Barker GJ; Thompson AJ; Miller DH
Mult Scler; 2003 Dec; 9(6):566-73. PubMed ID: 14664468
[TBL] [Abstract][Full Text] [Related]
3. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.
Zivadinov R; Rudick RA; De Masi R; Nasuelli D; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
Neurology; 2001 Oct; 57(7):1239-47. PubMed ID: 11591843
[TBL] [Abstract][Full Text] [Related]
4. Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis.
Richert ND; Ostuni JL; Bash CN; Leist TP; McFarland HF; Frank JA
Mult Scler; 2001 Feb; 7(1):49-58. PubMed ID: 11321194
[TBL] [Abstract][Full Text] [Related]
5. Magnetization transfer imaging to monitor the evolution of MS: a 1-year follow-up study.
Filippi M; Inglese M; Rovaris M; Sormani MP; Horsfield P; Iannucci PG; Colombo B; Comi G
Neurology; 2000 Oct; 55(7):940-6. PubMed ID: 11061248
[TBL] [Abstract][Full Text] [Related]
6. A semiautomated measure of whole-brain atrophy in multiple sclerosis.
Bermel RA; Sharma J; Tjoa CW; Puli SR; Bakshi R
J Neurol Sci; 2003 Apr; 208(1-2):57-65. PubMed ID: 12639726
[TBL] [Abstract][Full Text] [Related]
7. Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFNbeta-1b.
Rao AB; Richert N; Howard T; Lewis BK; Bash CN; McFarland HF; Frank JA
Neurology; 2002 Sep; 59(5):688-94. PubMed ID: 12221158
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis: chemokine receptor expression on circulating lymphocytes in correlation with radiographic measures of tissue injury.
Fox RJ; Kivisakk P; Fisher E; Tucky B; Lee JC; Rudick RA; Ransohoff RM
Mult Scler; 2008 Sep; 14(8):1036-43. PubMed ID: 18701575
[TBL] [Abstract][Full Text] [Related]
9. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.
De Stefano N; Battaglini M; Stromillo ML; Zipoli V; Bartolozzi ML; Guidi L; Siracusa G; Portaccio E; Giorgio A; Sorbi S; Federico A; Amato MP
Brain; 2006 Aug; 129(Pt 8):2008-16. PubMed ID: 16815879
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal microstructural MRI markers of demyelination and neurodegeneration in early relapsing-remitting multiple sclerosis: Magnetisation transfer, water diffusion and g-ratio.
York EN; Meijboom R; Thrippleton MJ; Bastin ME; Kampaite A; White N; Chandran S; Waldman AD;
Neuroimage Clin; 2022; 36():103228. PubMed ID: 36265199
[TBL] [Abstract][Full Text] [Related]
11. Short-term brain atrophy changes in relapsing-remitting multiple sclerosis.
Zivadinov R; Bagnato F; Nasuelli D; Bastianello S; Bratina A; Locatelli L; Watts K; Finamore L; Grop A; Dwyer M; Catalan M; Clemenzi A; Millefiorini E; Bakshi R; Zorzon M
J Neurol Sci; 2004 Aug; 223(2):185-93. PubMed ID: 15337621
[TBL] [Abstract][Full Text] [Related]
12. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease.
Vrenken H; Pouwels PJ; Ropele S; Knol DL; Geurts JJ; Polman CH; Barkhof F; Castelijns JA
Mult Scler; 2007 Jul; 13(6):708-16. PubMed ID: 17613597
[TBL] [Abstract][Full Text] [Related]
13. Significance of T2 lesions in multiple sclerosis: A 13-year longitudinal study.
Rudick RA; Lee JC; Simon J; Fisher E
Ann Neurol; 2006 Aug; 60(2):236-42. PubMed ID: 16786526
[TBL] [Abstract][Full Text] [Related]
14. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.
Tavazzi E; Dwyer MG; Weinstock-Guttman B; Lema J; Bastianello S; Bergamaschi R; Cosi V; Benedict RH; Munschauer FE; Zivadinov R
Neuroimage; 2007 Jul; 36(3):746-54. PubMed ID: 17498974
[TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis.
Zivadinov R; Zorzon M; De Masi R; Nasuelli D; Cazzato G
J Neurol Sci; 2008 Apr; 267(1-2):28-35. PubMed ID: 17945260
[TBL] [Abstract][Full Text] [Related]
16. A magnetization transfer histogram study of normal-appearing brain tissue in MS.
Tortorella C; Viti B; Bozzali M; Sormani MP; Rizzo G; Gilardi MF; Comi G; Filippi M
Neurology; 2000 Jan; 54(1):186-93. PubMed ID: 10636146
[TBL] [Abstract][Full Text] [Related]
17. Regional patterns of grey matter atrophy and magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups: a voxel-based analysis study.
Mallik S; Muhlert N; Samson RS; Sethi V; Wheeler-Kingshott CA; Miller DH; Chard DT
Mult Scler; 2015 Apr; 21(4):423-32. PubMed ID: 25145689
[TBL] [Abstract][Full Text] [Related]
18. Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis.
Hardmeier M; Wagenpfeil S; Freitag P; Fisher E; Rudick RA; Kooijmans-Coutinho M; Clanet M; Radue EW; Kappos L;
Arch Neurol; 2003 Dec; 60(12):1736-9. PubMed ID: 14676048
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis.
Nos C; Sastre-Garriga J; Borràs C; Río J; Tintoré M; Montalban X
Mult Scler; 2004 Aug; 10(4):413-6. PubMed ID: 15327039
[TBL] [Abstract][Full Text] [Related]
20. MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis.
Stosic M; Ambrus J; Garg N; Weinstock-Guttman B; Ramanathan M; Kalman B; Minagar A; Munschauer FE; Galey TM; Hussein S; Bakshi R; Zivadinov R
J Neurol; 2010 Jan; 257(1):63-71. PubMed ID: 19633967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
